Control

US Interactive Residential Security Market to Grow by USD 2.97 Billion (2024-2028), Rising Crime Rates and AI Innovations Drive Market - Technavio Report

Retrieved on: 
Thursday, September 12, 2024
Cloud, USB On-The-Go, Apartment, Electronics, Safety, Power management, Growth, AI, Security, Access control, Facial recognition, Honeywell, Ring (company), Home, Internet, Theft, Control, Artificial intelligence, Interactivity, Home automation, DIY, Machine learning, ADT, RMON, Personal, Alphabet Inc., Software

The interactive residential security market in the US is witnessing significant growth due to vendors' increasing focus on new product development.

Key Points: 
  • The interactive residential security market in the US is witnessing significant growth due to vendors' increasing focus on new product development.
  • Such new innovations by vendors will continue to drive the growth of the interactive residential security market in the US during the forecast period.
  • The Interactive Residential Security market in the US is thriving, with a focus on advanced safety measures for homes.
  • Failure to address cost concerns may limit market growth potential in the US interactive residential security market during the forecast period.

Mitsubishi Tanabe Pharma America to Present Latest Neurodegenerative Research at the 2024 American Neurological Association 149th Annual Meeting

Retrieved on: 
Thursday, September 12, 2024
Parkinson's disease, Edaravone, MBA, American Neurological Association, Safety, Doctor of Pharmacy, FDA, Boundless, Control, PD, ALS, Annual general meeting, Abstract, Randomness, ANA, MTPA, PCPP, Superior, MHA, Disease, Pharmaceutical industry

JERSEY CITY, N.J., Sept. 12, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced four presentations will be shared at the American Neurological Association (ANA) 2024 Annual Meeting being held September 14-17 in Orlando, Fla. The presentations will discuss two abstracts in Parkinson's disease (PD) and two in amyotrophic lateral sclerosis (ALS).

Key Points: 
  • JERSEY CITY, N.J., Sept. 12, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced four presentations will be shared at the American Neurological Association (ANA) 2024 Annual Meeting being held September 14-17 in Orlando, Fla.
  • The presentations will discuss two abstracts in Parkinson's disease (PD) and two in amyotrophic lateral sclerosis (ALS).
  • "We look forward to sharing the latest findings from our studies in Parkinson's disease and ALS at this year's ANA meeting," said Gustavo A. Suarez Zambrano, M.D., Vice President of Medical Affairs, MTPA.
  • "Our presentations underscore our unwavering commitment to understanding the high unmet needs within these patient communities through continuous research and innovation."

CTR Investments & Consulting, Inc. Announces a Change of Control and New Officers and Directors

Retrieved on: 
Thursday, September 12, 2024
Control, OTC Markets Group, Investment, Change

PALM DESERT, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- CTR Investments & Consulting, Inc. (Pink Open Markets: CIVX) announced today that on September 6, 2024, the controlling shareholders of CTR Investments & Consulting, Inc. (the “Company”), Cavan C. Carlson, Craig C. Carlson, and Rebecca Sue Iodice (the “Sellers”), closed a transaction with Financial Capital Group LLC, a Nevada limited liability company (the “Buyer”) whereby the Sellers sold their controlling interests in the Company to the Buyer.

Key Points: 
  • PALM DESERT, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- CTR Investments & Consulting, Inc. (Pink Open Markets: CIVX) announced today that on September 6, 2024, the controlling shareholders of CTR Investments & Consulting, Inc. (the “Company”), Cavan C. Carlson, Craig C. Carlson, and Rebecca Sue Iodice (the “Sellers”), closed a transaction with Financial Capital Group LLC, a Nevada limited liability company (the “Buyer”) whereby the Sellers sold their controlling interests in the Company to the Buyer.
  • At the same time, Cavan C. Carlson resigned as an officer and director of the Company and James E. Shipley, the controlling party and managing member of the Buyer, was elected as a director, President, Secretary, and Treasurer/CFO of the Company.
  • No further information was disclosed except for that included in our Supplemental Disclosure for Change of Control Events posted to OTC Markets Group, Inc. as of this date.

PharmAla to supply Johns Hopkins Medicine for Clinical Trial

Retrieved on: 
Wednesday, September 11, 2024
Communication, Research, MDXX, Safety, IRB, Clinical trial, MDMA, OTC, Pharmacology, Control, GMP, Pharmaceutical industry

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is proud to announce that it has been contracted as a supplier of MDMA to a clinical trial at Johns Hopkins Medicine.

Key Points: 
  • TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is proud to announce that it has been contracted as a supplier of MDMA to a clinical trial at Johns Hopkins Medicine.
  • “We’re looking forward to continuing to provide exceptional service – as well as robust investigational drug product – to researchers in the US and around the world,” said Nicholas Kadysh, CEO, PharmAla Biotech.
  • PharmAla is confident that it can offer research customers rapid support to convert their clinical trial registrations and IRB approvals to the LaNeo MDMA Chemistry, Manufacturing and Control package.
  • PharmAla is disclosing that the Company initiated procedures to terminate its agreement with Red Light Holland, and that said contract was concluded on September 3, 2024.

Genetec expands Security Center SaaS with the launch of Operations Center, the industry’s first work management solution for physical security operations

Retrieved on: 
Wednesday, September 11, 2024
Communication, GSX, Checklist, Product engineering, Partner, Privacy, Security, Statistics, Brigham Young, Control, Student

MONTREAL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), a leading technology provider of unified security, public safety, operations, and business intelligence solutions, today announced the launch of Operations Center, a cloud-based work management solution designed specifically for physical security operations. Available as part of Security Center SaaS, or as a standalone product, this new solution is specifically designed for security operations professionals and will revolutionize the way physical security teams collaborate, communicate, and manage their tasks.

Key Points: 
  • MONTREAL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), a leading technology provider of unified security, public safety, operations, and business intelligence solutions, today announced the launch of Operations Center , a cloud-based work management solution designed specifically for physical security operations.
  • Available as part of Security Center SaaS , or as a standalone product, this new solution is specifically designed for security operations professionals and will revolutionize the way physical security teams collaborate, communicate, and manage their tasks.
  • Genetec™ Operations Center addresses the operational challenges faced by Security Operations teams, which often rely on spreadsheets or disconnected work management tools designed for IT or other departments.
  • Operations Center solves this by integrating security dispatching, work ticketing, and activity tracking into a single platform.

Genetec expands Security Center SaaS with the launch of Operations Center, the industry’s first work management solution for physical security operations

Retrieved on: 
Wednesday, September 11, 2024
Communication, GSX, Checklist, Product engineering, Partner, Privacy, Security, Statistics, Brigham Young, Control, Student

Montreal, Canada, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), a leading technology provider of unified security, public safety, operations, and business intelligence solutions, today announced the launch of Operations Center , a cloud-based work management solution designed specifically for physical security operations.

Key Points: 
  • Montreal, Canada, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), a leading technology provider of unified security, public safety, operations, and business intelligence solutions, today announced the launch of Operations Center , a cloud-based work management solution designed specifically for physical security operations.
  • Available as part of Security Center SaaS , or as a standalone product, this new solution is specifically designed for security operations professionals and will revolutionize the way physical security teams collaborate, communicate, and manage their tasks.
  • Genetec™ Operations Center addresses the operational challenges faced by Security Operations teams, which often rely on spreadsheets or disconnected work management tools designed for IT or other departments.
  • Operations Center solves this by integrating security dispatching, work ticketing, and activity tracking into a single platform.

Ameresco’s Memphis LED Streetlighting Project Receives Recognition from U.S. Department of Energy’s 2024 Integrated Lighting Campaign

Retrieved on: 
Wednesday, September 11, 2024
Technology, Other Defense, Contracts, Sustainability, Public Safety, Public Policy, Government, Other Construction & Property, Building Systems, Defense, Construction & Property, Environment, Other Energy, Urban Planning, Utilities, Green Technology, Alternative Energy, Energy, Other Technology, White House, Federal Government, State, Local, Hardware, LED, Data collection, Safety, Network, Life, DOE, Climate change, GHG, City, AMRC, Organization, Quality of life, Environmental issues, Electricity, Integration, Quality, Pedestrian, Kilowatt-hour, Carbon, Energy efficiency, Water, Control, ILC, EVP, Renewable energy

Additionally, the project will result in an estimated 55% reduction in energy costs, translating to substantial financial savings for the city.

Key Points: 
  • Additionally, the project will result in an estimated 55% reduction in energy costs, translating to substantial financial savings for the city.
  • Key Highlights of the Project:
    Energy Efficiency – The new LED streetlights consume significantly less energy than traditional fixtures, contributing to Memphis's broader sustainability goals.
  • “It’s an honor to receive this recognition from the U.S. Department of Energy,” said Doug McGowen, president and CEO of Memphis Light, Gas and Water.
  • The 2024 campaign recognized 16 organizations for their exemplary commitment to energy efficiency and environmental responsibility in their buildings and outdoor spaces.

Wellness App CoughPro Unveils First-Ever AI Driven Cough Management Feature

Retrieved on: 
Wednesday, September 11, 2024
Language, Urge, FDA, Marie Cassidy, Cough, CXO, Disease, Chronic cough, Food, Control, Speech, Poultry farming

WILMIGTON, Del., Sept. 11, 2024 /PRNewswire-PRWeb/ -- CoughPro, the global leader in consumer cough tracking and monitoring, proudly announces the launch of its pioneering Cough Management feature, marking a global first in digital wellness. Cough Management is now available within the CoughPro app, offering science-based, actionable lifestyle and behavioral content for individuals struggling with chronic cough conditions.

Key Points: 
  • Welness app CoughPro unveils the world's first digital Cough Management feature, offering AI-driven solutions for millions suffering from chronic cough.
  • Cough Management is now available within the CoughPro app, offering science-based, actionable lifestyle and behavioral content for individuals struggling with chronic cough conditions.
  • Powered by the principles of Behavioral Cough Suppression and Hyfe's state-of-the-art cough detection, CoughPro's Cough Management leverages cutting-edge AI technology to offer users a science-backed approach to taking control of their cough.
  • CoughPro – and the Cough Management feature – is currently available as a wellness app and is not intended to diagnose, treat, cure, or prevent any disease.

Rivus Pharmaceuticals Strengthens Executive Team and Board with Appointments of Tom O'Neil as Chief Financial Officer and Erin Lavelle as Director

Retrieved on: 
Wednesday, September 11, 2024
MBA, Therapy, Audit committee, Economics, Global marketing, Obesity, Growth, Lundbeck Seattle Biopharmaceuticals, Control, Amgen, CFO, Merrill (company), Corporate development, Metabolism, Metabolic disorder, Arcadia Biosciences, Sorbent, Accounting, Yale University, MASH, SAN, Management

CHARLOTTESVILLE, Va. and SAN FRANCISCO, Sept. 11, 2024 /PRNewswire/ -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving metabolic health, today announced it has appointed Tom O'Neil as chief financial officer and Erin Lavelle as an independent member of its board of directors. Mr. O'Neil will be responsible for leading the finance, accounting and corporate strategy functions for the company. Ms. Lavelle will lead the formation of the company's Audit Committee.

Key Points: 
  • "We are thrilled to welcome Tom as our chief financial officer.
  • "Erin is a seasoned biopharmaceutical executive with robust operational, financial and M&A experience.
  • He served as chief financial officer for Satsuma Pharmaceuticals, Protagonist Therapeutics, Arcadia Biosciences and Sorbent Therapeutics.
  • She previously served as chief operating officer and chief financial officer at ProfoundBio and as the chief operating officer and chief financial officer at Eliem Therapeutics.

FXGT.com Launches Optimus: A Powerful New Account for Ambitious Traders Seeking High Leverage

Retrieved on: 
Wednesday, September 11, 2024
Risk, Control, Risk management, Tourism

FXGT.com's introduction of the Optimus account reinforces its position as a leading global broker committed to providing innovative and client-centric trading solutions.

Key Points: 
  • FXGT.com's introduction of the Optimus account reinforces its position as a leading global broker committed to providing innovative and client-centric trading solutions.
  • Designed with short-term trading in mind, the Optimus account caters to traders who want to take advantage of short-term market movements.
  • This enhanced leverage empowers traders to open larger positions with smaller capital, offering the potential to capture greater market opportunities.
  • In addition to its powerful leverage, the Optimus account also provides traders with cost-effective market access.